Tvardi Therapeutics, Inc. (TVRD)
NASDAQ·Healthcare·Biotechnology
$2.34
-4.10%
Mkt Cap $23.55M
Analyst Ratings
Buy
3
Hold
2
Sell
1
Price Target (5 analysts)
$3.00
Range $3.00 – $3.00
Implied Upside
+28.2%
Consensus $3.00 vs current $2.34
NASDAQ·Healthcare·Biotechnology
$2.34
-4.10%
Mkt Cap $23.55M
Buy
3
Hold
2
Sell
1
Price Target (5 analysts)
$3.00
Range $3.00 – $3.00
+28.2%
Consensus $3.00 vs current $2.34